Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
galleonpharma.com

See what CB Insights has to offer

Executives

4

Board of Directors

2

Galleon Pharmaceuticals Board of Directors

2 Board of directors

Galleon Pharmaceuticals has 2 board of directors, including Christopher Mirabelli.

Name

Firm

Work History

Other Seats

Christopher Mirabelli

Dr. Christopher Mirabelli has spent over 35 years in the pharmaceutical and biotechnology industries as a research scientist, senior executive, and venture capital investor. Currently, he is a managing director of the venture capital firm HealthCare Ventures. Dr. Mirabelli is currently Chairman of the Board of Directors of Leap Therapeutics, where he was the Chief Executive Officer from its founding in 2015 until 2020. Previously, Dr. Mirabelli was Chief Executive Officer and Chairman of the Board of Directors of LeukoSite from its founding in 1993 until its acquisition by Millennium Pharmaceuticals in 1999. Dr. Mirabelli was also a Co-Founder of Ionis Pharmaceuticals. He began his industry career in R&D at SmithKline & French Laboratories, and earned his Ph.D. in Molecular Pharmacology from Baylor College of Medicine and his B.S. in Biology from State University of New York (SUNY) at Fredonia.

Galleon Pharmaceuticals

Ralph Christoffersen

Galleon Pharmaceuticals

Name

Christopher Mirabelli

Ralph Christoffersen

Firm

Work History

Dr. Christopher Mirabelli has spent over 35 years in the pharmaceutical and biotechnology industries as a research scientist, senior executive, and venture capital investor. Currently, he is a managing director of the venture capital firm HealthCare Ventures. Dr. Mirabelli is currently Chairman of the Board of Directors of Leap Therapeutics, where he was the Chief Executive Officer from its founding in 2015 until 2020. Previously, Dr. Mirabelli was Chief Executive Officer and Chairman of the Board of Directors of LeukoSite from its founding in 1993 until its acquisition by Millennium Pharmaceuticals in 1999. Dr. Mirabelli was also a Co-Founder of Ionis Pharmaceuticals. He began his industry career in R&D at SmithKline & French Laboratories, and earned his Ph.D. in Molecular Pharmacology from Baylor College of Medicine and his B.S. in Biology from State University of New York (SUNY) at Fredonia.

Other Seats

Galleon Pharmaceuticals

Galleon Pharmaceuticals

Galleon Pharmaceuticals Management Team

4 Team Members

Galleon Pharmaceuticals has 4 executives. Galleon Pharmaceuticals's current Chief Executive Officer, President is Jim Mannion.

Name

Work History

Title

Status

Jim Mannion

Chief Executive Officer, President

Current

Euan MacIntyre

Senior Vice President

Current

James McLeod M.D.

Chief Medical Officer, Senior Vice President

Former

Douglas Hay

Senior Vice President

Former

Name

Jim Mannion

Euan MacIntyre

James McLeod M.D.

Douglas Hay

Work History

Title

Chief Executive Officer, President

Senior Vice President

Chief Medical Officer, Senior Vice President

Senior Vice President

Status

Current

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.